In summary, decreased serum concentration of IGF1 seems to be a potential risk factor for HCC progression, while levels of circulating IGF2 (increased or decreased in HCC, according the different data) is a rather uncertain marker of hepatocarcinogenesis. Here, IGF2 is linked to hepatocellular carcinoma.